Showing results (1391-1400 of 1,996) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|September 12, 2014
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 studyThomas Voit, Haluk Topaloglu, Volker Straub, et al.The Lancet. Neurology|September 19, 2014
The role of iron in brain ageing and neurodegenerative disordersRoberta J Ward, Fabio A Zucca, Jeff H Duyn, et al.The Lancet. Neurology|July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trialRobert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.The Lancet. Neurology|August 16, 2014
The challenge and promise of anti-epileptic therapy development in animal modelsMichele Simonato, Amy R Brooks-Kayal, Jerome Engel, et al.The Lancet. Neurology|August 22, 2014
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and researchAmy Waldman, Angelo Ghezzi, Amit Bar-Or, et al.The Lancet. Neurology|April 20, 2026
Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association studyKathrine E Attfield, Angelos P Armen, Subita Balaram Kuttikkatte, et al.The Lancet. Neurology|December 17, 2011
Stroke risk in women: the role of menopause and hormone therapyLynda Lisabeth, Cheryl BushnellThe Lancet. Neurology|May 9, 2026
Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trialUrs Fischer, Alex Brehm, Marc Ribo, et al.The Lancet. Neurology|May 13, 2026
Diagnosis and pathogenesis of dystonia: clinical heterogeneity, shared mechanisms, and neurodevelopmental originsEmmanuel Roze, Verity M McClelland, Lara M Lange, et al.Pageof 200